Tonix Pharmaceuticals
(NASDAQ) TNXP
Tonix Pharmaceuticals Financials at a Glance
Market Cap
$184.32M
Revenue (TTM)
$13.11M
Net Income (TTM)
$124.02M
EPS (TTM)
$-14.26
P/E Ratio
-0.96
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$13.84
Volume
5,635
Open
$14.39
Price
$13.84
Volume
5,635
Open
$14.39
Previous Close
$13.84
Daily Range
$13.80 - $14.93
52-Week Range
$13.07 - $69.97
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$13.84
Volume
5,635
Open
$14.39
Previous Close
$13.84
Daily Range
$13.80 - $14.93
52-Week Range
$13.07 - $69.97
TNXP News
TNXP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tonix Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Seth Lederman, MD
Website
www.tonixpharma.comHeadquarters
Chatham, NJ 07928, US
TNXP Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
-10%
Net Income Margin
-9%
Return on Equity
-64%
Return on Capital
-51%
Return on Assets
-45%
Earnings Yield
-1.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$184.32M
Shares Outstanding
13.41M
Volume
5.63K
Short Interest
0.00%
Avg. Volume
418.04K
Financials (TTM)
Gross Profit
$6.47M
Operating Income
$125.70M
EBITDA
$123.78M
Operating Cash Flow
$99.84M
Capital Expenditure
$3.37M
Free Cash Flow
$103.21M
Cash & ST Invst.
$207.64M
Total Debt
$1.31M
Tonix Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.39M
+108.8%
Gross Profit
$4.33M
+209.6%
Gross Margin
80.37%
N/A
Market Cap
$184.32M
N/A
Market Cap/Employee
$2.28M
N/A
Employees
81
N/A
Net Income
$46.91M
-112.2%
EBITDA
$48.29M
-123.4%
Quarterly Fundamentals
Net Cash
$206.33M
+120.7%
Accounts Receivable
$9.76M
+23.4%
Inventory
$6.01M
-28.5%
Long Term Debt
$1.18M
-76.4%
Short Term Debt
$125.00K
-54.4%
Return on Assets
-44.75%
N/A
Return on Invested Capital
-51.03%
N/A
Free Cash Flow
$41.52M
-183.8%
Operating Cash Flow
$39.65M
-171.0%